152 results on '"Martin, Clémence"'
Search Results
2. CT imaging shows specific pancreatic abnormalities in persons with cystic fibrosis related diabetes
3. “Il faut continuer à poser des questions” patient reported outcome measures in cystic fibrosis: An anthropological perspective
4. Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function
5. Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues
6. Impact of panelists’ experience on script concordance test scores of medical students
7. Chatbot-based serious games: A useful tool for training medical students? A randomized controlled trial
8. Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis
9. Causes of death in French cystic fibrosis patients: The need for improvement in transplantation referral strategies!
10. The French Compassionate Program of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with advanced lung disease and no F508delCFTRvariant
11. Neuraminidase is a host‐directed approach to regulate neutrophil responses in sepsis and COVID‐19
12. Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin
13. Normalisation of circulating neutrophil counts after 12 months of elexacaftor-tezacaftor-ivacaftor in patients with advanced cystic fibrosis
14. Specific circulating neutrophils subsets are present in clinically stable adults with cystic fibrosis and are further modulated by pulmonary exacerbations
15. Prognostic value of six minute walk test in cystic fibrosis adults
16. Cystic Fibrosis in 2021: “The Times They Are A-Changin”
17. Reclassifying inconclusive diagnosis for cystic fibrosis with new generation sweat test
18. Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study
19. CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France
20. Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis
21. Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension
22. Neutrophil-Expressed p21/waf1 Favors Inflammation Resolution in Pseudomonas aeruginosa Infection
23. Using chest CT scan and unsupervised machine learning for predicting and evaluating response to lumacaftor-ivacaftor in people with cystic fibrosis
24. “Il faut continuer à poser des questions” patient reported outcome measures in cystic fibrosis: An anthropological perspective
25. Improved survival albeit with persistent disparities in prognosis for people with cystic fibrosis in European countries
26. Inhaled Dual Phosphodiesterase 3/4 Inhibitors for the Treatment of Patients with COPD: A Short Review
27. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
28. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis
29. Additional file 4 of Impact of panelists’ experience on script concordance test scores of medical students
30. Additional file 6 of Impact of panelists’ experience on script concordance test scores of medical students
31. Additional file 1 of Impact of panelists’ experience on script concordance test scores of medical students
32. Additional file 2 of Impact of panelists’ experience on script concordance test scores of medical students
33. Additional file 3 of Impact of panelists’ experience on script concordance test scores of medical students
34. Additional file 5 of Impact of panelists’ experience on script concordance test scores of medical students
35. Lung immunoglobulin A immunity dysregulation in cystic fibrosis
36. Safety of Omalizumab During Pregnancy and Breast-Feeding With Assessment of Placental Transfer: A Case Report
37. Quantification of Cystic Fibrosis Lung Disease with Radiomics-based CT Scores
38. Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient
39. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
40. Effective control ofStaphylococcus aureuslung infection despite tertiary lymphoid structure disorganisation
41. Lung immunoglobulin A immunity dysregulation in cystic fibrosis
42. Carriers of a single CFTR mutation are asymptomatic: an evolving dogma?
43. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis
44. Increased IgA Expression in Lung Lymphoid Follicles in Severe COPD
45. Increased IgA Expression in Lung Lymphoid Follicles in Severe COPD.
46. Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy
47. Cured bronchi! Extending the use of nebulised hypertonic saline outside of cystic fibrosis?
48. Bronchodilator Response Assessment of the Small Airways Obstructive Pattern
49. Bacteria-driven peribronchial lymphoid neogenesis in bronchiectasis and cystic fibrosis
50. Host-microbe interactions in distal airways: relevance to chronic airway diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.